| developmental process (GO:0032502) | 1.36 | 5 | APC, PTCH2, BRCA2, SUFU, CTNNB1 |
| multicellular organismal process (GO:0032501) | 1.45 | 5 | APC, PTCH2, BRCA2, SUFU, CTNNB1 |
| single-multicellular organism process (GO:0044707) | 1.78 | 5 | APC, PTCH2, BRCA2, SUFU, CTNNB1 |
| anatomical structure development (GO:0048856) | 1.58 | 5 | APC, PTCH2, BRCA2, SUFU, CTNNB1 |
| regulation of cellular process (GO:0050794) | 0.5 | 5 | APC, PTCH2, BRCA2, SUFU, CTNNB1 |
| biological regulation (GO:0065007) | 0.39 | 5 | APC, PTCH2, BRCA2, SUFU, CTNNB1 |
| animal organ development (GO:0048513) | 2.53 | 5 | APC, PTCH2, BRCA2, SUFU, CTNNB1 |
| single-organism cellular process (GO:0044763) | 0.65 | 5 | APC, PTCH2, BRCA2, SUFU, CTNNB1 |
| negative regulation of cellular process (GO:0048523) | 1.41 | 5 | APC, PTCH2, BRCA2, SUFU, CTNNB1 |
| negative regulation of biological process (GO:0048519) | 1.33 | 5 | APC, PTCH2, BRCA2, SUFU, CTNNB1 |
| cellular process (GO:0009987) | 0.26 | 5 | APC, PTCH2, BRCA2, SUFU, CTNNB1 |
| regulation of biological process (GO:0050789) | 0.45 | 5 | APC, PTCH2, BRCA2, SUFU, CTNNB1 |
| single-organism process (GO:0044699) | 0.48 | 5 | APC, PTCH2, BRCA2, SUFU, CTNNB1 |
| signal transduction (GO:0007165) | 1.28 | 5 | APC, PTCH2, BRCA2, SUFU, CTNNB1 |
| negative regulation of metabolic process (GO:0009892) | 1.93 | 4 | APC, SUFU, BRCA2, CTNNB1 |
| metabolic process (GO:0008152) | 0.58 | 4 | APC, SUFU, BRCA2, CTNNB1 |
| regulation of metabolic process (GO:0019222) | 1.02 | 4 | APC, SUFU, BRCA2, CTNNB1 |
| negative regulation of response to stimulus (GO:0048585) | 2.52 | 4 | APC, PTCH2, SUFU, CTNNB1 |
| negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 4 | APC, SUFU, BRCA2, CTNNB1 |
| regulation of response to stimulus (GO:0048583) | 1.54 | 4 | APC, PTCH2, SUFU, CTNNB1 |
| negative regulation of signaling (GO:0023057) | 2.65 | 4 | APC, PTCH2, SUFU, CTNNB1 |
| negative regulation of cell communication (GO:0010648) | 2.66 | 4 | APC, PTCH2, SUFU, CTNNB1 |
| regulation of signaling (GO:0023051) | 1.72 | 4 | APC, PTCH2, SUFU, CTNNB1 |
| regulation of cell communication (GO:0010646) | 1.73 | 4 | APC, PTCH2, SUFU, CTNNB1 |
| regulation of primary metabolic process (GO:0080090) | 1.08 | 4 | APC, SUFU, BRCA2, CTNNB1 |
| negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 4 | APC, SUFU, BRCA2, CTNNB1 |
| negative regulation of signal transduction (GO:0009968) | 2.75 | 4 | APC, PTCH2, SUFU, CTNNB1 |
| regulation of signal transduction (GO:0009966) | 1.84 | 4 | APC, PTCH2, SUFU, CTNNB1 |
| cellular developmental process (GO:0048869) | 1.82 | 4 | APC, PTCH2, BRCA2, CTNNB1 |
| organic substance metabolic process (GO:0071704) | 0.63 | 4 | APC, SUFU, BRCA2, CTNNB1 |
| positive regulation of biological process (GO:0048518) | 1.2 | 4 | APC, PTCH2, BRCA2, CTNNB1 |
| regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 4 | APC, SUFU, BRCA2, CTNNB1 |
| regulation of cellular metabolic process (GO:0031323) | 1.07 | 4 | APC, SUFU, BRCA2, CTNNB1 |
| single-organism developmental process (GO:0044767) | 1.49 | 4 | APC, SUFU, BRCA2, CTNNB1 |
| regulation of cell differentiation (GO:0045595) | 2.42 | 4 | APC, PTCH2, SUFU, CTNNB1 |
| regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 4 | APC, SUFU, BRCA2, CTNNB1 |
| regulation of multicellular organismal process (GO:0051239) | 1.87 | 4 | PTCH2, BRCA2, SUFU, CTNNB1 |
| primary metabolic process (GO:0044238) | 0.69 | 4 | APC, SUFU, BRCA2, CTNNB1 |
| protein metabolic process (GO:0019538) | 1.45 | 4 | APC, SUFU, BRCA2, CTNNB1 |
| regulation of developmental process (GO:0050793) | 2.1 | 4 | PTCH2, BRCA2, SUFU, CTNNB1 |
| macromolecule metabolic process (GO:0043170) | 0.83 | 4 | APC, SUFU, BRCA2, CTNNB1 |
| regulation of multicellular organismal development (GO:2000026) | 2.31 | 4 | PTCH2, BRCA2, SUFU, CTNNB1 |
| positive regulation of cellular process (GO:0048522) | 1.3 | 4 | APC, PTCH2, BRCA2, CTNNB1 |
| positive regulation of metabolic process (GO:0009893) | 1.74 | 3 | APC, BRCA2, CTNNB1 |
| negative regulation of biosynthetic process (GO:0009890) | 2.47 | 3 | SUFU, BRCA2, CTNNB1 |
| regulation of cell cycle process (GO:0010564) | 3.5 | 3 | APC, BRCA2, CTNNB1 |
| macromolecular complex subunit organization (GO:0043933) | 2.14 | 3 | APC, BRCA2, CTNNB1 |
| regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 3 | SUFU, BRCA2, CTNNB1 |
| cell surface receptor signaling pathway (GO:0007166) | 2.09 | 3 | APC, SUFU, CTNNB1 |
| negative regulation of protein modification process (GO:0031400) | 3.4 | 3 | APC, SUFU, CTNNB1 |
| multicellular organism development (GO:0007275) | 2.54 | 3 | SUFU, BRCA2, CTNNB1 |
| cellular component organization or biogenesis (GO:0071840) | 1.22 | 3 | APC, BRCA2, CTNNB1 |
| pattern specification process (GO:0007389) | 3.79 | 3 | APC, SUFU, CTNNB1 |
| cellular response to stimulus (GO:0051716) | 1.97 | 3 | APC, BRCA2, CTNNB1 |
| positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 3 | APC, BRCA2, CTNNB1 |
| cellular macromolecule metabolic process (GO:0044260) | 0.93 | 3 | APC, BRCA2, CTNNB1 |
| cell fate specification (GO:0001708) | 5.57 | 3 | APC, PTCH2, CTNNB1 |
| negative regulation of multicellular organismal process (GO:0051241) | 2.84 | 3 | SUFU, BRCA2, CTNNB1 |
| regulation of protein metabolic process (GO:0051246) | 1.93 | 3 | APC, SUFU, CTNNB1 |
| negative regulation of cellular macromolecule biosynthetic process (GO:2000113) | 2.6 | 3 | SUFU, BRCA2, CTNNB1 |
| cellular component organization (GO:0016043) | 1.24 | 3 | APC, BRCA2, CTNNB1 |
| localization (GO:0051179) | 1.4 | 3 | SUFU, BRCA2, CTNNB1 |
| negative regulation of developmental process (GO:0051093) | 3.17 | 3 | SUFU, BRCA2, CTNNB1 |
| negative regulation of cellular biosynthetic process (GO:0031327) | 2.49 | 3 | SUFU, BRCA2, CTNNB1 |
| regulation of protein modification process (GO:0031399) | 2.32 | 3 | APC, SUFU, CTNNB1 |
| proteolysis (GO:0006508) | 2.73 | 3 | APC, SUFU, CTNNB1 |
| regulation of molecular function (GO:0065009) | 1.78 | 3 | APC, SUFU, CTNNB1 |
| regulation of biological quality (GO:0065008) | 1.68 | 3 | SUFU, BRCA2, CTNNB1 |
| regulation of gene expression (GO:0010468) | 1.37 | 3 | SUFU, BRCA2, CTNNB1 |
| skin development (GO:0043588) | 5.84 | 3 | PTCH2, SUFU, CTNNB1 |
| regulation of cell proliferation (GO:0042127) | 2.41 | 3 | APC, BRCA2, CTNNB1 |
| negative regulation of cell proliferation (GO:0008285) | 3.26 | 3 | APC, BRCA2, CTNNB1 |
| negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | 2.55 | 3 | SUFU, BRCA2, CTNNB1 |
| regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 3 | SUFU, BRCA2, CTNNB1 |
| regulation of biosynthetic process (GO:0009889) | 1.37 | 3 | SUFU, BRCA2, CTNNB1 |
| regulation of mitotic cell cycle (GO:0007346) | 3.71 | 3 | APC, BRCA2, CTNNB1 |
| regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 3 | SUFU, BRCA2, CTNNB1 |
| regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 3 | SUFU, BRCA2, CTNNB1 |
| negative regulation of nitrogen compound metabolic process (GO:0051172) | 2.47 | 3 | SUFU, BRCA2, CTNNB1 |
| regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 3 | SUFU, BRCA2, CTNNB1 |
| response to chemical (GO:0042221) | 1.98 | 3 | APC, BRCA2, CTNNB1 |
| regulation of localization (GO:0032879) | 1.94 | 3 | APC, SUFU, CTNNB1 |
| response to organic substance (GO:0010033) | 2.2 | 3 | APC, BRCA2, CTNNB1 |
| response to oxygen-containing compound (GO:1901700) | 2.57 | 3 | APC, BRCA2, CTNNB1 |
| negative regulation of cellular protein metabolic process (GO:0032269) | 2.88 | 3 | APC, SUFU, CTNNB1 |
| regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 3 | APC, SUFU, CTNNB1 |
| regulation of cell cycle (GO:0051726) | 2.93 | 3 | APC, BRCA2, CTNNB1 |
| response to stimulus (GO:0050896) | 1.22 | 3 | APC, BRCA2, CTNNB1 |
| regulation of RNA metabolic process (GO:0051252) | 1.52 | 3 | SUFU, BRCA2, CTNNB1 |
| cellular metabolic process (GO:0044237) | 0.69 | 3 | APC, BRCA2, CTNNB1 |
| regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 3 | SUFU, BRCA2, CTNNB1 |
| regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 3 | SUFU, BRCA2, CTNNB1 |
| negative regulation of protein metabolic process (GO:0051248) | 2.82 | 3 | APC, SUFU, CTNNB1 |
| negative regulation of macromolecule biosynthetic process (GO:0010558) | 2.53 | 3 | SUFU, BRCA2, CTNNB1 |
| regulation of smoothened signaling pathway (GO:0008589) | 5.62 | 2 | PTCH2, SUFU |
| regulation of phosphate metabolic process (GO:0019220) | 2.35 | 2 | APC, CTNNB1 |
| anatomical structure homeostasis (GO:0060249) | 4.25 | 2 | BRCA2, CTNNB1 |
| regulation of transport (GO:0051049) | 2.24 | 2 | SUFU, CTNNB1 |
| cell maturation (GO:0048469) | 4.98 | 2 | BRCA2, CTNNB1 |
| skeletal system development (GO:0001501) | 4.49 | 2 | SUFU, CTNNB1 |
| organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 2 | BRCA2, CTNNB1 |
| cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114) | 3.79 | 2 | APC, CTNNB1 |
| organic cyclic compound metabolic process (GO:1901360) | 1.26 | 2 | BRCA2, CTNNB1 |
| negative regulation of cell cycle (GO:0045786) | 3.67 | 2 | APC, CTNNB1 |
| regulation of cytoskeleton organization (GO:0051493) | 3.72 | 2 | APC, CTNNB1 |
| response to growth factor (GO:0070848) | 4.14 | 2 | APC, CTNNB1 |
| regulation of osteoblast differentiation (GO:0045667) | 4.99 | 2 | SUFU, CTNNB1 |
| regulation of epithelial cell differentiation (GO:0030856) | 4.96 | 2 | PTCH2, CTNNB1 |
| negative regulation of molecular function (GO:0044092) | 2.74 | 2 | APC, SUFU |
| positive regulation of epithelial cell differentiation (GO:0030858) | 5.76 | 2 | PTCH2, CTNNB1 |
| cytokinesis (GO:0000910) | 5.22 | 2 | APC, BRCA2 |
| regulation of DNA metabolic process (GO:0051052) | 3.87 | 2 | BRCA2, CTNNB1 |
| establishment of protein localization (GO:0045184) | 2.53 | 2 | BRCA2, CTNNB1 |
| developmental process involved in reproduction (GO:0003006) | 3.36 | 2 | BRCA2, CTNNB1 |
| regionalization (GO:0003002) | 4.24 | 2 | SUFU, CTNNB1 |
| regulation of embryonic development (GO:0045995) | 4.98 | 2 | SUFU, CTNNB1 |
| cellular response to growth factor stimulus (GO:0071363) | 4.27 | 2 | APC, CTNNB1 |
| tube formation (GO:0035148) | 4.98 | 2 | SUFU, CTNNB1 |
| heterocycle metabolic process (GO:0046483) | 1.31 | 2 | BRCA2, CTNNB1 |
| regulation of phosphorylation (GO:0042325) | 2.5 | 2 | APC, CTNNB1 |
| cellular catabolic process (GO:0044248) | 2.62 | 2 | APC, CTNNB1 |
| single organism reproductive process (GO:0044702) | 2.73 | 2 | BRCA2, CTNNB1 |
| response to external stimulus (GO:0009605) | 2.55 | 2 | BRCA2, CTNNB1 |
| cell motility (GO:0048870) | 3.02 | 2 | APC, CTNNB1 |
| Wnt signaling pathway (GO:0016055) | 3.88 | 2 | APC, CTNNB1 |
| cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 2 | BRCA2, CTNNB1 |
| cellular response to stress (GO:0033554) | 2.51 | 2 | APC, BRCA2 |
| aromatic compound biosynthetic process (GO:0019438) | 1.7 | 2 | BRCA2, CTNNB1 |
| regulation of microtubule cytoskeleton organization (GO:0070507) | 4.98 | 2 | APC, CTNNB1 |
| regulation of catabolic process (GO:0009894) | 3.52 | 2 | APC, SUFU |
| cellular component assembly (GO:0022607) | 2.14 | 2 | APC, CTNNB1 |
| cellular macromolecule biosynthetic process (GO:0034645) | 1.66 | 2 | BRCA2, CTNNB1 |
| positive regulation of biosynthetic process (GO:0009891) | 2.29 | 2 | BRCA2, CTNNB1 |
| movement of cell or subcellular component (GO:0006928) | 2.61 | 2 | APC, CTNNB1 |
| negative regulation of gene expression (GO:0010629) | 2.48 | 2 | SUFU, CTNNB1 |
| positive regulation of gene expression (GO:0010628) | 2.35 | 2 | BRCA2, CTNNB1 |
| negative regulation of RNA biosynthetic process (GO:1902679) | 2.7 | 2 | SUFU, CTNNB1 |
| regulation of apoptotic process (GO:0042981) | 2.5 | 2 | APC, CTNNB1 |
| organic substance biosynthetic process (GO:1901576) | 1.34 | 2 | BRCA2, CTNNB1 |
| organic substance catabolic process (GO:1901575) | 2.45 | 2 | APC, CTNNB1 |
| cellular macromolecule catabolic process (GO:0044265) | 3.19 | 2 | APC, CTNNB1 |
| regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 2 | SUFU, CTNNB1 |
| macromolecular complex assembly (GO:0065003) | 2.55 | 2 | APC, CTNNB1 |
| cell migration (GO:0016477) | 3.12 | 2 | APC, CTNNB1 |
| anatomical structure formation involved in morphogenesis (GO:0048646) | 3.01 | 2 | SUFU, CTNNB1 |
| heterocycle biosynthetic process (GO:0018130) | 1.7 | 2 | BRCA2, CTNNB1 |
| positive regulation of cellular component organization (GO:0051130) | 2.68 | 2 | APC, CTNNB1 |
| beta-catenin destruction complex disassembly (GO:1904886) | 6.64 | 2 | APC, CTNNB1 |
| regulation of catalytic activity (GO:0050790) | 1.97 | 2 | APC, CTNNB1 |
| tissue development (GO:0009888) | 3.27 | 2 | PTCH2, CTNNB1 |
| negative regulation of smoothened signaling pathway (GO:0045879) | 6.55 | 2 | PTCH2, SUFU |
| canonical Wnt signaling pathway (GO:0060070) | 5.26 | 2 | APC, CTNNB1 |
| response to stress (GO:0006950) | 1.8 | 2 | APC, BRCA2 |
| hemopoiesis (GO:0030097) | 5.07 | 2 | BRCA2, CTNNB1 |
| nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 2 | BRCA2, CTNNB1 |
| regulation of ossification (GO:0030278) | 4.53 | 2 | SUFU, CTNNB1 |
| establishment of localization (GO:0051234) | 1.48 | 2 | BRCA2, CTNNB1 |
| positive regulation of cell differentiation (GO:0045597) | 3.01 | 2 | PTCH2, CTNNB1 |
| proteolysis involved in cellular protein catabolic process (GO:0051603) | 3.59 | 2 | APC, CTNNB1 |
| dorsal/ventral pattern formation (GO:0009953) | 5.6 | 2 | SUFU, CTNNB1 |
| proteasomal protein catabolic process (GO:0010498) | 4.12 | 2 | APC, CTNNB1 |
| regulation of transferase activity (GO:0051338) | 2.88 | 2 | APC, CTNNB1 |
| positive regulation of macromolecule biosynthetic process (GO:0010557) | 2.39 | 2 | BRCA2, CTNNB1 |
| regulation of nervous system development (GO:0051960) | 3.1 | 2 | SUFU, CTNNB1 |
| response to alcohol (GO:0097305) | 4.58 | 2 | APC, CTNNB1 |
| regulation of chromosome organization (GO:0033044) | 4.11 | 2 | APC, CTNNB1 |
| regulation of sister chromatid segregation (GO:0033045) | 5.63 | 2 | APC, CTNNB1 |
| regulation of organelle organization (GO:0033043) | 2.72 | 2 | APC, CTNNB1 |
| pancreas development (GO:0031016) | 6.47 | 2 | APC, CTNNB1 |
| negative regulation of cellular component organization (GO:0051129) | 3.35 | 2 | APC, CTNNB1 |
| regulation of cellular component organization (GO:0051128) | 2.01 | 2 | APC, CTNNB1 |
| regulation of cellular protein localization (GO:1903827) | 3.43 | 2 | SUFU, CTNNB1 |
| embryo development (GO:0009790) | 4.2 | 2 | BRCA2, CTNNB1 |
| regulation of protein catabolic process (GO:0042176) | 3.83 | 2 | APC, SUFU |
| embryo development ending in birth or egg hatching (GO:0009792) | 4.35 | 2 | BRCA2, CTNNB1 |
| cellular response to chemical stimulus (GO:0070887) | 2.57 | 2 | APC, CTNNB1 |
| regulation of microtubule-based process (GO:0032886) | 4.79 | 2 | APC, CTNNB1 |
| anatomical structure morphogenesis (GO:0009653) | 2.53 | 2 | SUFU, CTNNB1 |
| protein complex disassembly (GO:0043241) | 4.58 | 2 | APC, CTNNB1 |
| response to organic cyclic compound (GO:0014070) | 3.07 | 2 | BRCA2, CTNNB1 |
| regulation of protein localization (GO:0032880) | 2.88 | 2 | SUFU, CTNNB1 |
| response to endogenous stimulus (GO:0009719) | 2.79 | 2 | APC, CTNNB1 |
| nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 2 | BRCA2, CTNNB1 |
| negative regulation of transcription from RNA polymerase II promoter (GO:0000122) | 3.12 | 2 | SUFU, CTNNB1 |
| proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161) | 4.16 | 2 | APC, CTNNB1 |
| cell fate determination (GO:0001709) | 5.97 | 2 | PTCH2, CTNNB1 |
| positive regulation of protein metabolic process (GO:0051247) | 2.43 | 2 | APC, CTNNB1 |
| regulation of protein modification by small protein conjugation or removal (GO:1903320) | 4.14 | 2 | SUFU, CTNNB1 |
| negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 4.8 | 2 | SUFU, CTNNB1 |
| epithelial tube morphogenesis (GO:0060562) | 5.12 | 2 | SUFU, CTNNB1 |
| chordate embryonic development (GO:0043009) | 4.38 | 2 | BRCA2, CTNNB1 |
| biological adhesion (GO:0022610) | 2.81 | 2 | APC, CTNNB1 |
| cellular response to endogenous stimulus (GO:0071495) | 3.33 | 2 | APC, CTNNB1 |
| reproductive structure development (GO:0048608) | 4.08 | 2 | BRCA2, CTNNB1 |
| cell proliferation (GO:0008283) | 3.23 | 2 | BRCA2, CTNNB1 |
| establishment of protein localization to organelle (GO:0072594) | 3.92 | 2 | BRCA2, CTNNB1 |
| modification-dependent protein catabolic process (GO:0019941) | 3.71 | 2 | APC, CTNNB1 |
| negative regulation of nucleic acid-templated transcription (GO:1903507) | 2.71 | 2 | SUFU, CTNNB1 |
| cellular response to DNA damage stimulus (GO:0006974) | 3.17 | 2 | APC, BRCA2 |
| negative regulation of cell differentiation (GO:0045596) | 3.33 | 2 | SUFU, CTNNB1 |
| negative regulation of transcription, DNA-templated (GO:0045892) | 2.75 | 2 | SUFU, CTNNB1 |
| positive regulation of transcription, DNA-templated (GO:0045893) | 2.56 | 2 | BRCA2, CTNNB1 |
| cell-cell junction organization (GO:0045216) | 4.66 | 2 | APC, CTNNB1 |
| cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 2 | BRCA2, CTNNB1 |
| cell junction assembly (GO:0034329) | 4.86 | 2 | APC, CTNNB1 |
| regulation of chromosome segregation (GO:0051983) | 5.38 | 2 | APC, CTNNB1 |
| nucleic acid metabolic process (GO:0090304) | 1.46 | 2 | BRCA2, CTNNB1 |
| regulation of sequence-specific DNA binding transcription factor activity (GO:0051090) | 3.83 | 2 | SUFU, CTNNB1 |
| regulation of epithelial cell proliferation (GO:0050678) | 4.06 | 2 | BRCA2, CTNNB1 |
| positive regulation of developmental process (GO:0051094) | 2.77 | 2 | PTCH2, CTNNB1 |
| negative regulation of RNA metabolic process (GO:0051253) | 2.66 | 2 | SUFU, CTNNB1 |
| response to drug (GO:0042493) | 3.71 | 2 | APC, CTNNB1 |
| positive regulation of RNA metabolic process (GO:0051254) | 2.51 | 2 | BRCA2, CTNNB1 |
| positive regulation of RNA biosynthetic process (GO:1902680) | 2.54 | 2 | BRCA2, CTNNB1 |
| nitrogen compound metabolic process (GO:0006807) | 1.13 | 2 | BRCA2, CTNNB1 |
| system development (GO:0048731) | 2.92 | 2 | SUFU, CTNNB1 |
| gland development (GO:0048732) | 4.15 | 2 | BRCA2, CTNNB1 |
| positive regulation of nucleic acid-templated transcription (GO:1903508) | 2.56 | 2 | BRCA2, CTNNB1 |
| regulation of cellular localization (GO:0060341) | 3.03 | 2 | SUFU, CTNNB1 |
| positive regulation of cellular biosynthetic process (GO:0031328) | 2.3 | 2 | BRCA2, CTNNB1 |
| positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 2 | BRCA2, CTNNB1 |
| cell junction organization (GO:0034330) | 4.51 | 2 | APC, CTNNB1 |
| homeostatic process (GO:0042592) | 2.61 | 2 | BRCA2, CTNNB1 |
| cell cycle process (GO:0022402) | 2.75 | 2 | APC, BRCA2 |
| positive regulation of cellular component biogenesis (GO:0044089) | 3.71 | 2 | APC, CTNNB1 |
| positive regulation of cell death (GO:0010942) | 3.32 | 2 | APC, CTNNB1 |
| tube morphogenesis (GO:0035239) | 4.35 | 2 | SUFU, CTNNB1 |
| modification-dependent macromolecule catabolic process (GO:0043632) | 3.69 | 2 | APC, CTNNB1 |
| regulation of cell death (GO:0010941) | 2.43 | 2 | APC, CTNNB1 |
| morphogenesis of an epithelium (GO:0002009) | 4.08 | 2 | SUFU, CTNNB1 |
| response to estradiol (GO:0032355) | 4.73 | 2 | BRCA2, CTNNB1 |
| protein complex subunit organization (GO:0071822) | 2.6 | 2 | APC, CTNNB1 |
| chromatin organization (GO:0006325) | 3.28 | 2 | BRCA2, CTNNB1 |
| response to lipid (GO:0033993) | 3.11 | 2 | BRCA2, CTNNB1 |
| negative regulation of nervous system development (GO:0051961) | 4.15 | 2 | SUFU, CTNNB1 |
| regulation of programmed cell death (GO:0043067) | 2.49 | 2 | APC, CTNNB1 |
| positive regulation of apoptotic process (GO:0043065) | 3.38 | 2 | APC, CTNNB1 |
| cellular response to organic substance (GO:0071310) | 2.78 | 2 | APC, CTNNB1 |
| ubiquitin-dependent protein catabolic process (GO:0006511) | 3.72 | 2 | APC, CTNNB1 |
| tissue morphogenesis (GO:0048729) | 3.87 | 2 | SUFU, CTNNB1 |
| hematopoietic or lymphoid organ development (GO:0048534) | 4.49 | 2 | BRCA2, CTNNB1 |
| positive regulation of programmed cell death (GO:0043068) | 3.38 | 2 | APC, CTNNB1 |
| embryonic morphogenesis (GO:0048598) | 3.72 | 2 | SUFU, CTNNB1 |
| negative regulation of mitotic cell cycle (GO:0045930) | 4.45 | 2 | APC, CTNNB1 |
| positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | 2.35 | 2 | BRCA2, CTNNB1 |
| cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 2 | BRCA2, CTNNB1 |
| protein complex assembly (GO:0006461) | 2.78 | 2 | APC, CTNNB1 |
| macromolecular complex disassembly (GO:0032984) | 4.53 | 2 | APC, CTNNB1 |
| regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 2 | APC, CTNNB1 |
| reproductive process (GO:0022414) | 2.55 | 2 | BRCA2, CTNNB1 |
| biosynthetic process (GO:0009058) | 1.32 | 2 | BRCA2, CTNNB1 |
| macromolecule biosynthetic process (GO:0009059) | 1.61 | 2 | BRCA2, CTNNB1 |
| cellular component disassembly (GO:0022411) | 3.52 | 2 | APC, CTNNB1 |
| cellular process involved in reproduction in multicellular organism (GO:0022412) | 4.3 | 2 | BRCA2, CTNNB1 |
| cell adhesion (GO:0007155) | 2.82 | 2 | APC, CTNNB1 |
| catabolic process (GO:0009056) | 2.38 | 2 | APC, CTNNB1 |
| macromolecule catabolic process (GO:0009057) | 3.0 | 2 | APC, CTNNB1 |
| single-organism localization (GO:1902578) | 2.09 | 2 | SUFU, CTNNB1 |
| locomotion (GO:0040011) | 2.91 | 2 | APC, CTNNB1 |
| response to abiotic stimulus (GO:0009628) | 2.8 | 2 | BRCA2, CTNNB1 |
| positive regulation of nitrogen compound metabolic process (GO:0051173) | 2.29 | 2 | BRCA2, CTNNB1 |
| negative regulation of embryonic development (GO:0045992) | 6.47 | 2 | SUFU, CTNNB1 |
| regulation of cellular component biogenesis (GO:0044087) | 3.08 | 2 | APC, CTNNB1 |
| developmental maturation (GO:0021700) | 4.7 | 2 | BRCA2, CTNNB1 |
| regulation of protein phosphorylation (GO:0001932) | 2.57 | 2 | APC, CTNNB1 |
| cellular biosynthetic process (GO:0044249) | 1.37 | 2 | BRCA2, CTNNB1 |
| protein catabolic process (GO:0030163) | 3.93 | 2 | APC, CTNNB1 |